Skip to Main Content

Paper Details

Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets.
Gastroenterology
25
2022
ACADS, CD, Crohn's disease, IBD, IBD genetic susceptibility loci, IBD risk loci, Inflammatory Bowel Disease, TMEM229B, UC, butyrate, fatty acid, fatty acid desaturase 1/2 locus, genetic loci, inflammatory bowel disease, mQTL, non-overlapping loci, omega, patients, serum, ulcerative colitis
Author NameAffiliation
Sander M HoutenIcahn School of Medicine at Mount Sinai, New York Icahn Institute for Data Science and Genomic Technology
Aleksandar Stojmirovic
Jun ZhuIcahn School of Medicine at Mount Sinai, Connecticut Icahn Institute for Data Science and Genomic Technology
Judy H ChoIcahn School of Medicine at Mount Sinai
Marla C DubinskyIcahn School of Medicine at Mount Sinai
Bruce E SandsIcahn School of Medicine at Mount Sinai
Eric E SchadtIcahn School of Medicine at Mount Sinai, Connecticut Icahn Institute for Data Science and Genomic Technology
Eric E SchadtIcahn School of Medicine at Mount Sinai, Connecticut Icahn Institute for Data Science and Genomic Technology
Jean-Frederic ColombelIcahn School of Medicine at Mount Sinai
Ke HaoIcahn School of Medicine at Mount Sinai, Connecticut Icahn Institute for Data Science and Genomic Technology
  • 1 - 10

Datasets

Release 1.2